Pacific Biosciences of California, Inc.
PACB
$1.37
-$0.01-0.73%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -16.73% | 16.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -16.73% | 16.14% | |||
| Cost of Revenue | -41.28% | 80.80% | |||
| Gross Profit | 210.18% | -73.02% | |||
| SG&A Expenses | -12.86% | 14.96% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -27.96% | 35.56% | |||
| Operating Income | 36.31% | -54.80% | |||
| Income Before Tax | 79.86% | -6.78% | |||
| Income Tax Expenses | -8.91% | -47.26% | |||
| Earnings from Continuing Operations | 79.50% | -6.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 79.50% | -6.24% | |||
| EBIT | 36.31% | -54.80% | |||
| EBITDA | 37.78% | -59.42% | |||
| EPS Basic | 79.73% | -5.86% | |||
| Normalized Basic EPS | 31.70% | -46.61% | |||
| EPS Diluted | 77.56% | -2.85% | |||
| Normalized Diluted EPS | 31.70% | -46.61% | |||
| Average Basic Shares Outstanding | 1.30% | 0.35% | |||
| Average Diluted Shares Outstanding | 1.30% | 0.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||